White label ELPA - ClinicalTrials.eu

Study on Human Fetal Neural Precursor Cells and Tacrolimus for Patients with Progressive Multiple Sclerosis

Recruiting

2 1 1 1
Investigated Diseases:
- Progressive multiple sclerosis
Investigated Drugs:
- Human Neuronal Progenitor/Stem Cells
- Tacrolimus
Study on Sequential Treatment with Gemcitabine, Paclitaxel, and FOLFIRINOX for Patients with Locally Advanced Pancreatic Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Pancreatic carcinoma
Investigated Drugs:
Study on Filgrastim for Patients with Severe Bullous Drug Eruptions: Lyell and Stevens-Johnson Syndromes

Recruiting

4 1 1
Investigated Diseases:
- Stevens-Johnson syndrome
- Toxic epidermal necrolysis
Investigated Drugs:
- Glucose Monohydrate
- Filgrastim
Study on the Safety and Tolerability of TUB-040 for Patients with Platinum-Resistant Ovarian Cancer or Relapsed/Refractory Non-Small Cell Lung Cancer

Recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- Tub-040
Study of tazemetostat combined with lenalidomide and rituximab in adult patients with relapsed or refractory follicular lymphoma

Recruiting

3 1 1
Investigated Diseases:
- Follicular lymphoma
Investigated Drugs:
+1
Study on the Use of Gallium Citrate Ga-68 for Diagnosing Chronic Infections in Artificial Hip and Knee Joints

Recruiting

2 1 1
Investigated Diseases:
- Medical device site joint infection
Investigated Drugs:
- Gallium Citrate Ga-68
Study of ADS-010 for Adults with Facioscapulohumeral Muscular Dystrophy Type 1

Recruiting

2 1 1
Investigated Diseases:
- Facioscapulohumeral muscular dystrophy
Investigated Drugs:
- Ads-010
- Sodium Chloride
Study on the Effect of Levobupivacaine in Reducing Chronic Pain After Open Inguinal Hernia Repair in Patients

Recruiting

3 1 1 1
Investigated Diseases:
Study on Leflunomide for Preventing Relapses in Patients with Polymyalgia Rheumatica During Steroid Reduction

Recruiting

3 1 1 1
Investigated Diseases:
- Polymyalgia rheumatica
Investigated Drugs:
- Leflunomide
- Placebo
Study of Nivolumab and Nivolumab Plus Relatlimab for Patients with Advanced or Metastatic Skin Squamous Cell Carcinoma

Recruiting

2 1 1 1
Investigated Diseases:
- Squamous cell carcinoma of skin
Investigated Drugs:
- Relatlimab
- Nivolumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies